These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17652687)

  • 1. Use of octreotide acetate to prevent rebound hypoglycaemia in sulfonylurea overdose.
    Hassan Z; Wright J
    Emerg Med J; 2007 Aug; 24(8):580-1. PubMed ID: 17652687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
    Lheureux PE; Zahir S; Penaloza A; Gris M
    Crit Care; 2005; 9(6):543-9. PubMed ID: 16356235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide for paediatric sulfonylurea poisonings.
    Osterhoudt KC
    J Paediatr Child Health; 2009; 45(7-8):473. PubMed ID: 19712185
    [No Abstract]   [Full Text] [Related]  

  • 4. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
    Carr R; Zed PJ
    Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylurea intoxication at a tertiary care paediatric hospital.
    Glatstein M; Garcia-Bournissen F; Scolnik D; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e51-6. PubMed ID: 20124602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
    Vallurupalli S
    Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children.
    Dougherty PP; Lee SC; Lung D; Klein-Schwartz W
    Pediatr Emerg Care; 2013 Mar; 29(3):292-5. PubMed ID: 23426239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide's role in the management of sulfonylurea-induced hypoglycemia.
    Dougherty PP; Klein-Schwartz W
    J Med Toxicol; 2010 Jun; 6(2):199-206. PubMed ID: 20352540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonylurea-induced hypoglycaemia: use of octreotide.
    Hanchard B; Boulouffe C; Vanpee D
    Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion.
    Rath S; Bar-Zeev N; Anderson K; Fahy R; Roseby R
    J Paediatr Child Health; 2008 Jun; 44(6):383-4. PubMed ID: 18476935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
    Groth CM; Banzon ER
    J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of sulfonylurea and insulin overdose.
    Klein-Schwartz W; Stassinos GL; Isbister GK
    Br J Clin Pharmacol; 2016 Mar; 81(3):496-504. PubMed ID: 26551662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of sulfonylurea ingestions.
    Spiller HA
    Pediatr Emerg Care; 1999 Jun; 15(3):227-30. PubMed ID: 10389964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR
    Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide therapy for nateglinide-induced hypoglycemia.
    Sherk DK; Bryant SM
    Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765
    [No Abstract]   [Full Text] [Related]  

  • 16. Octreotide for the treatment of sulfonylurea poisoning.
    Glatstein M; Scolnik D; Bentur Y
    Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor.
    Yamaguchi S; Ikejima M; Furukawa A; Abe M; Nakazaki M; Ishihara H
    Diabetes Res Clin Pract; 2015 Aug; 109(2):e8-e10. PubMed ID: 26025695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide.
    Pelavin PI; Abramson E; Pon S; Vogiatzi MG
    J Pediatr Endocrinol Metab; 2009 Feb; 22(2):171-5. PubMed ID: 19449674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminophylline in bradyasystolic cardiac arrest.
    Hayward E; Showler L; Soar J
    Emerg Med J; 2007 Aug; 24(8):582-3. PubMed ID: 17652689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
    Boyle PJ; Justice K; Krentz AJ; Nagy RJ; Schade DS
    J Clin Endocrinol Metab; 1993 Mar; 76(3):752-6. PubMed ID: 8445035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.